National Institute of Dental & Craniofacial Research; Notice of Closed Meetings, 8268-8269 [2022-03090]
Download as PDF
8268
Federal Register / Vol. 87, No. 30 / Monday, February 14, 2022 / Notices
disease area. The application forms will
be web-based.
OMB approval is requested for 3
years. There are no costs to respondents
other than their time. The total
annualized burden hours are 33.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
responses per
respondent
Average time
per response
(in hours)
Total annual
burden hour
Type of respondent
A. Application ....................................
B. Mentor Information and Agreement.
Applicant Scientists ..........................
Scientists ..........................................
25
25
1
1
1
20/60
25
8
Totals .........................................
...........................................................
........................
50
........................
33
Dated: February 9, 2022.
Lanette A. Palmquist,
Project Clearance Liaison, National Institute
on Drug Abuse, National Institutes of Health.
[FR Doc. 2022–03089 Filed 2–11–22; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
jspears on DSK121TN23PROD with NOTICES1
Number of
respondents
Form name
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Respiratory Sciences.
Date: March 10, 2022.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Xiang-Ning Li, MD, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5112,
MSC 7854, Bethesda, MD 20892, 301–435–
1744, lixiang@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR–20–
117: Maximizing Investigators Research
Award (MIRA) for Early Stage Investigators
(R35—Clinical Trial Optional).
Date: March 14–15, 2022.
VerDate Sep<11>2014
17:54 Feb 11, 2022
Jkt 256001
Time: 10:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Jimok Kim, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, 6107 Rockledge Drive,
Bethesda, MD 20892, (301) 402–8559,
jimok.kim@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Health
Services Organization, Delivery, Quality and
Effectiveness.
Date: March 15–16, 2022.
Time: 9:30 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Catherine Hadeler
Maulsby, Ph.D., Scientific Review Officer,
Center for Scientific Review, National
Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (301) 435–1266,
maulsbych@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Immune Responses and Vaccines
to Microbial Infections.
Date: March 16–17, 2022.
Time: 10:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Barna Dey, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3184,
Bethesda, MD 20892, 301–451–2796, bdey@
mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Medical Imaging.
Date: March 17–18, 2022.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Krystyna H. Szymczyk,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
PO 00000
Frm 00042
Fmt 4703
Sfmt 4703
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 480–4198, szymczykk@
csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR–20–
117: Maximizing Investigators’ Research
Award (MIRA) for Early Stage Investigators
(R35—Clinical Trial Optional).
Date: March 21–22, 2022.
Time: 10:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Thomas Y. Cho, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, 6701 Rockledge Drive,
Room 710B, Bethesda, MD 20892, 301–402–
4179, thomas.cho@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: February 8, 2022.
David W. Freeman,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2022–03053 Filed 2–11–22; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Dental &
Craniofacial Research; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
E:\FR\FM\14FEN1.SGM
14FEN1
8269
Federal Register / Vol. 87, No. 30 / Monday, February 14, 2022 / Notices
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Name of Committee: National Institute of
Dental and Craniofacial Research Special
Emphasis Panel; Understanding Oral Human
Papillomavirus (HPV) Infection, Acquisition,
and Persistence in People Living With HIV.
Date: March 10, 2022.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Dental and
Craniofacial Research, 6701 Democracy
Boulevard, Bethesda, MD 20892 (Virtual
Meeting).
Contact Person: Thomas John O’Farrell,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Activities,
National Institute of Dental and Craniofacial
Research, 6701 Democracy Blvd., Bethesda,
MD 20892, (301) 584–4859, tom.ofarrell@
nih.gov.
Name of Committee: National Institute of
Dental and Craniofacial Research Special
Emphasis Panel; Feasibility Studies That
Explore Healthy and Diseased TMJ Using
Single Cell Multi-Omic Analyses.
Date: March 11, 2022.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Dental and
Craniofacial Research, 6701 Democracy
Boulevard, Bethesda, MD 20892 (Virtual
Meeting).
Contact Person: Aiwu Cheng, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Activities,
National Institute of Dental and Craniofacial
Research, 6701 Democracy Blvd., Bethesda,
MD 20892, Aiwu.cheng@nih.gov.
(Catalogue of Federal Domestic Assistance
Program No. 93.121, Oral Diseases and
Disorders Research, National Institutes of
Health, HHS)
Agency Information Collection
Activities: Proposed Collection;
Comment Request
Dated: February 9, 2022.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
SAMHSA is requesting approval for
its Harm Reduction Grant Program
Annual Target Setting and Aggregate
Quarterly Reporting Instrument. In
developing the instrument, we sought to
elicit programmatic information that
[FR Doc. 2022–03090 Filed 2–11–22; 8:45 am]
BILLING CODE 4140–01–P
Substance Abuse and Mental Health
Services Administration
In compliance with Section
3506(c)(2)(A) of the Paperwork
Reduction Act of 1995 concerning
opportunity for public comment on
proposed collections of information, the
Substance Abuse and Mental Health
Services Administration (SAMHSA)
will publish periodic summaries of
proposed projects. To request more
information on the proposed projects or
to obtain a copy of the information
collection plans, call the SAMHSA
Reports Clearance Officer at (240) 276–
0361.
Comments are invited on: (a) Whether
the proposed collections of information
are necessary for the proper
performance of the functions of the
agency, including whether the
information shall have practical utility;
(b) the accuracy of the agency’s estimate
of the burden of the proposed collection
of information; (c) ways to enhance the
quality, utility, and clarity of the
information to be collected; and (d)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques or
other forms of information technology.
Project: Harm Reduction Grant
Program Target Setting and Quarterly
Aggregate Reporting Instrument—(OMB
No. 0930–XXXX)
demonstrates impact at the program
level aligned with the Notice of Funding
Opportunity. In this way, data from the
instrument can be used to assess
resource allocation and to delineate who
we serve, how we serve them, and
program impacts. The tool reflects
SAMHSA’s desire to elicit pertinent
program level data that can be used to
not only guide future programs and
practice, but to also respond to
stakeholder, congressional and agency
enquiries.
The information collected from these
forms is to be entered and stored in
SAMHSA’s Performance Accountability
and Reporting System, which is a realtime, performance management system
that captures information on the
substance abuse treatment and mental
health services delivered in the United
States. Approval of this information
collection will allow SAMHSA to
continue to meet GPRA reporting
requirements that quantify the effects
and accomplishments of its
discretionary grant programs, which are
consistent with OMB guidance.
SAMHSA and its Centers will use the
data for annual reporting required by
the Government Performance and
Results Act Modernization Act of 2010
(GPRMA). GPRMA requires that
SAMHSA’s fiscal year report include
actual results of performance
monitoring for the three preceding fiscal
years. The additional information
collected through this process will
allow SAMHSA to (1) report results of
these performance outcomes; (2)
maintain consistency with SAMHSAspecific performance domains, and (3)
assess the accountability and
performance of its discretionary and
formula grant programs.
TABLE 1—ESTIMATES OF ANNUALIZED HOUR BURDEN
Total
number of
responses
Burden
hours
per response
Total
burden
hours
Number of
respondents
Responses
per respondent
Target Setting Tool .............................................................
Aggregate Program Level Tool 2 .........................................
23
23
1
4
23
92
0.6
0.6
13.8
55.2
$24.78
24.78
$342
1,368
CSAP Total ..................................................................
23
..........................
115
....................
72
....................
1,710
SAMHSA tool
jspears on DSK121TN23PROD with NOTICES1
1 The
Hourly
wage 1
Total hour
cost
hourly wage estimate is $21.23 based on the Occupational Employment and Wages, Mean Hourly Wage Rate for 21–1011 Substance Abuse and Behavioral
Disorder Counselors = $24.78/hr. as of May 11, 2021. (https://www.bls.gov/oes/current/oes211011.htm. Accessed on May 11, 2021.)
2 This is an aggregate tool and collection is based on encounters.
VerDate Sep<11>2014
17:54 Feb 11, 2022
Jkt 256001
PO 00000
Frm 00043
Fmt 4703
Sfmt 4703
E:\FR\FM\14FEN1.SGM
14FEN1
Agencies
[Federal Register Volume 87, Number 30 (Monday, February 14, 2022)]
[Notices]
[Pages 8268-8269]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-03090]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Dental & Craniofacial Research; Notice of
Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material,
[[Page 8269]]
and personal information concerning individuals associated with the
grant applications, the disclosure of which would constitute a clearly
unwarranted invasion of personal privacy.
Name of Committee: National Institute of Dental and Craniofacial
Research Special Emphasis Panel; Understanding Oral Human
Papillomavirus (HPV) Infection, Acquisition, and Persistence in
People Living With HIV.
Date: March 10, 2022.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute of Dental and Craniofacial Research,
6701 Democracy Boulevard, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Thomas John O'Farrell, Scientific Review
Officer, Scientific Review Branch, Division of Extramural
Activities, National Institute of Dental and Craniofacial Research,
6701 Democracy Blvd., Bethesda, MD 20892, (301) 584-4859,
[email protected].
Name of Committee: National Institute of Dental and Craniofacial
Research Special Emphasis Panel; Feasibility Studies That Explore
Healthy and Diseased TMJ Using Single Cell Multi-Omic Analyses.
Date: March 11, 2022.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute of Dental and Craniofacial Research,
6701 Democracy Boulevard, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Aiwu Cheng, Ph.D., Scientific Review Officer,
Scientific Review Branch, Division of Extramural Activities,
National Institute of Dental and Craniofacial Research, 6701
Democracy Blvd., Bethesda, MD 20892, [email protected].
(Catalogue of Federal Domestic Assistance Program No. 93.121, Oral
Diseases and Disorders Research, National Institutes of Health, HHS)
Dated: February 9, 2022.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-03090 Filed 2-11-22; 8:45 am]
BILLING CODE 4140-01-P